Facebook
Twitter
PinterestThis site is intended for patients and caregivers.
Disclaimer | Privacy Policy | Contact Us | Prescribing Information
VYVGART is a registered trademark of argenx.
VYVGART Hytrulo is a trademark of argenx.
For U.S. audiences only.
About VYVGART Hytrulo
What is VYVGART Hytrulo?
VYVGART Hytrulo is the first-of-its-kind subcutaneous injection for chronic inflammatory demyelinating polyneuropathy (CIDP). The treatment is one injection given weekly that takes ~30 to 90 seconds. After administering your injection, your healthcare provider will monitor you for allergic reactions for at least 30 minutes.
Have an open conversation with your neurologist to explain your CIDP experience and goals. This may help your neurologist determine if VYVGART Hytrulo is the right fit for you.
How does VYVGART Hytrulo work?
VYVGART Hytrulo is specifically designed to attach to and block the neonatal Fc receptor (FcRn). This can help cause a reduction in the number of IgG antibodies, including the harmful IgG antibodies.
How often do I need to receive VYVGART Hytrulo injections?
VYVGART Hytrulo is one injection given weekly by a healthcare professional that takes ~30 to 90 seconds. After administering your injection, your healthcare provider will monitor you for allergic reactions for at least 30 minutes.
What are the most common side effects of VYVGART Hytrulo?
The most common side effects were:
- Respiratory tract infection
- Headache
- Urinary tract infection
- Tingling sensation
- Muscle pain
- Injection site reaction
What should I do if I miss an injection?
If you miss a scheduled injection, VYVGART Hytrulo may be given up to 3 days after the scheduled injection day. If you don’t receive the treatment within 3 days, your doctor will administer it at the next regularly scheduled treatment.
How is VYVGART Hytrulo pronounced?
VYVGART Hytrulo is pronounced VIV-gart hy-TRUE-lo.
Who can I talk to for more information about VYVGART Hytrulo?
If you have not yet been prescribed VYVGART Hytrulo for CIDP, you can talk to your doctor or call 1‑833‑VYV‑CIDP (1‑833‑898‑2437) to speak with an educator about CIDP, how VYVGART Hytrulo works, study data, cost and coverage, and more.
Ability tracking
Why should I track my symptoms and abilities?
Tracking your symptoms and abilities can help you and your doctor get a clearer picture of how CIDP is affecting you. This may help you define your goals and help your doctor determine the right CIDP treatment for you.
How do I track my symptoms and abilities?
Once you are prescribed VYVGART Hytrulo, you can enroll in My VYVGART Path and a Nurse Case Manager can provide personalized support, including help tracking your symptoms and abilities, and understanding your treatment.
Patient support
What is My VYVGART Path?
My VYVGART Path is a Patient Support Program that provides personalized support from a Nurse Case Manager and committed support team.
How do I join the My VYVGART Path program?
After you and your doctor decide on VYVGART Hytrulo for CIDP, your doctor’s office will be able to enroll you in My VYVGART Path. Then, a Nurse Case Manager will call, welcome you to the program, and offer assistance as you start your treatment journey. Or you can enroll yourself using the enrollment form available to download below.
How can a Nurse Case Manager help me during treatment with VYVGART Hytrulo?
Nurse Case Managers are knowledgeable about CIDP and VYVGART Hytrulo and are dedicated to listening to you and helping you navigate your VYVGART Hytrulo treatment journey. They can help you understand your treatment, feel empowered with resources and information, navigate the insurance process, and learn about potential financial assistance programs.
Where can I find more information about CIDP?
You can always reach out to your doctor to learn more about CIDP. Another resource is exploring patient advocacy organizations such as the Guillain-Barré syndrome (GBS)|CIDP foundation, a global nonprofit organization supporting individuals and their families affected by CIDP and related conditions through a commitment to support, education, research, and advocacy.
Learn more about VYVGART Hytrulo
Cost and coverage
Find resources and information that may help you navigate your VYVGART Hytrulo treatment for CIDP.
Glossary of CIDP terms
This list of commonly used terms can help you and your loved ones better understand CIDP.
CIDP=chronic inflammatory demyelinating polyneuropathy
Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
VYVGART HYTRULO may cause serious side effects, including:
- Infection. VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
- Allergic Reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
- Infusion-Related Reactions. VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.
Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.
Before taking VYVGART HYTRULO, tell your doctor if you:
- take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
- have received or are scheduled to receive a vaccine (immunization), or
- have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.
What are the common side effects of VYVGART HYTRULO?
The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.
These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.
What is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc)?
VYVGART HYTRULO is a prescription medicine used for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP)
Please see the full Prescribing Information for VYVGART HYTRULO and talk to your doctor.
IMPORTANT SAFETY INFORMATION
Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
VYVGART HYTRULO may cause serious side effects, including:
- Infection. VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
- Allergic Reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
- Infusion-Related Reactions. VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.
Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.
Before taking VYVGART HYTRULO, tell your doctor if you:
- take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
- have received or are scheduled to receive a vaccine (immunization), or
- have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.
What are the common side effects of VYVGART HYTRULO?
The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.
These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.
What is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc)?
VYVGART HYTRULO is a prescription medicine used for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP)
Please see the full Prescribing Information for VYVGART HYTRULO and talk to your doctor.
Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
VYVGART HYTRULO may cause serious side effects, including:
- Infection. VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
- Allergic Reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
- Infusion-Related Reactions. VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.
Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.
Before taking VYVGART HYTRULO, tell your doctor if you:
- take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
- have received or are scheduled to receive a vaccine (immunization), or
- have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.
What are the common side effects of VYVGART HYTRULO?
The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.
These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.
What is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc)?
VYVGART HYTRULO is a prescription medicine used for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP)
Please see the full Prescribing Information for VYVGART HYTRULO and talk to your doctor.
©2024 argenx
US-VYV_HYT-24-00018 V2 09/2024
